Lab supplies and equipment - sedia rapid recency kits

Ended Purchase Order Awarded

Contract number
75D30123P17526
Awardee
Awarding agency
Obligated
$82,263

Award facts

Contract value 100% obligated
$82,263.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30341, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Centers for Disease Control and Prevention (CDC) awarded an $82,263 firm fixed price purchase order to Sedia Biosciences Corporation for laboratory supplies and equipment to support rapid recency kits. Sedia Biosciences, doing business as Sedia Biosciences Corp., will deliver the requested supplies and equipment from its location in Chamblee, Georgia to support CDC programs in Pittsburgh, Pennsylvania by December 30, 2023. No subcontractors or set aside designations were identified. The award provides supplies and equipment to the CDC, the nation's leading public health agency, as it works to monitor and prevent disease.

Quick answers

Who was awarded contract 75D30123P17526?

75D30123P17526 was awarded to Sedia Biosciences Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 15, 2023.

How much is contract 75D30123P17526 worth?

The government has obligated $82,263 on 75D30123P17526.

Was contract 75D30123P17526 competed?

The extent of competition for 75D30123P17526 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login